Related references
Note: Only part of the references are listed.Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume
GC Jayson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Opinion - Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
YH Cao
NATURE REVIEWS CANCER (2005)
Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction
PLR Andrews et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
